Trying to separate three different claims about phenylpiracetam: that it is the right molecule, that it is the right dose, and that it does something useful.
Most of the popular protocols are borrowed from clinical populations and applied to healthy people without comment.
There is a serious question about whether the studied form matches what is sold, and nobody in a thread can answer it.
Headache is the classic first-week effect and choline usually sorts it.
Happy to be corrected on any of the above.
Baseline first. Not on phenylpiracetam but the pattern is familiar.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Loose evidence and no evidence are different, and people overcorrect in both directions. Eight months in on phenylpiracetam and it lines up.
Same here.